Postmenopausal Vaginal Atrophy Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Postmenopausal Vaginal Atrophy Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Postmenopausal Vaginal Atrophy Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Postmenopausal Vaginal Atrophy Therapeutics Overall Market Size
2.1 Global Postmenopausal Vaginal Atrophy Therapeutics Market Size: 2022 VS 2032
2.2 Global Postmenopausal Vaginal Atrophy Therapeutics Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Postmenopausal Vaginal Atrophy Therapeutics Players in Global Market
3.2 Top Global Postmenopausal Vaginal Atrophy Therapeutics Companies Ranked by Revenue
3.3 Global Postmenopausal Vaginal Atrophy Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Postmenopausal Vaginal Atrophy Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Postmenopausal Vaginal Atrophy Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Postmenopausal Vaginal Atrophy Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Postmenopausal Vaginal Atrophy Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Postmenopausal Vaginal Atrophy Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Markets, 2022 & 2032
4.1.2 Estrogen-based Drugs
4.1.3 Non-estrogen-based Drugs
4.2 By Type - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue, 2024-2032
4.2.3 By Type - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Specialist Clinic
5.2 By Application - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue, 2024-2032
5.2.3 By Application - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2022 & 2032
6.2 By Region - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue, 2024-2032
6.2.3 By Region - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Postmenopausal Vaginal Atrophy Therapeutics Revenue, 2018-2032
6.3.2 US Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.3.3 Canada Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.3.4 Mexico Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Postmenopausal Vaginal Atrophy Therapeutics Revenue, 2018-2032
6.4.2 Germany Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.4.3 France Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.4.4 U.K. Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.4.5 Italy Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.4.6 Russia Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.4.7 Nordic Countries Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.4.8 Benelux Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Postmenopausal Vaginal Atrophy Therapeutics Revenue, 2018-2032
6.5.2 China Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.5.3 Japan Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.5.4 South Korea Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.5.5 Southeast Asia Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.5.6 India Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Postmenopausal Vaginal Atrophy Therapeutics Revenue, 2018-2032
6.6.2 Brazil Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.6.3 Argentina Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Revenue, 2018-2032
6.7.2 Turkey Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.7.3 Israel Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.7.4 Saudi Arabia Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
6.7.5 UAE Postmenopausal Vaginal Atrophy Therapeutics Market Size, 2018-2032
7 Postmenopausal Vaginal Atrophy Therapeutics Companies Profiles
7.1 Endoceutics
7.1.1 Endoceutics Company Summary
7.1.2 Endoceutics Business Overview
7.1.3 Endoceutics Postmenopausal Vaginal Atrophy Therapeutics Major Product Offerings
7.1.4 Endoceutics Postmenopausal Vaginal Atrophy Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Endoceutics Key News & Latest Developments
7.2 Accord Healthcare
7.2.1 Accord Healthcare Company Summary
7.2.2 Accord Healthcare Business Overview
7.2.3 Accord Healthcare Postmenopausal Vaginal Atrophy Therapeutics Major Product Offerings
7.2.4 Accord Healthcare Postmenopausal Vaginal Atrophy Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Accord Healthcare Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Postmenopausal Vaginal Atrophy Therapeutics Major Product Offerings
7.3.4 Pfizer Postmenopausal Vaginal Atrophy Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Postmenopausal Vaginal Atrophy Therapeutics Major Product Offerings
7.4.4 Novo Nordisk Postmenopausal Vaginal Atrophy Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Novo Nordisk Key News & Latest Developments
7.5 Teva Pharmaceuticals
7.5.1 Teva Pharmaceuticals Company Summary
7.5.2 Teva Pharmaceuticals Business Overview
7.5.3 Teva Pharmaceuticals Postmenopausal Vaginal Atrophy Therapeutics Major Product Offerings
7.5.4 Teva Pharmaceuticals Postmenopausal Vaginal Atrophy Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Teva Pharmaceuticals Key News & Latest Developments
7.6 Shionogi
7.6.1 Shionogi Company Summary
7.6.2 Shionogi Business Overview
7.6.3 Shionogi Postmenopausal Vaginal Atrophy Therapeutics Major Product Offerings
7.6.4 Shionogi Postmenopausal Vaginal Atrophy Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Shionogi Key News & Latest Developments
7.7 Bionovo
7.7.1 Bionovo Company Summary
7.7.2 Bionovo Business Overview
7.7.3 Bionovo Postmenopausal Vaginal Atrophy Therapeutics Major Product Offerings
7.7.4 Bionovo Postmenopausal Vaginal Atrophy Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Bionovo Key News & Latest Developments
7.8 QuatRx Pharmaceutical Company
7.8.1 QuatRx Pharmaceutical Company Company Summary
7.8.2 QuatRx Pharmaceutical Company Business Overview
7.8.3 QuatRx Pharmaceutical Company Postmenopausal Vaginal Atrophy Therapeutics Major Product Offerings
7.8.4 QuatRx Pharmaceutical Company Postmenopausal Vaginal Atrophy Therapeutics Revenue in Global Market (2018-2023)
7.8.5 QuatRx Pharmaceutical Company Key News & Latest Developments
7.9 Bayer AG
7.9.1 Bayer AG Company Summary
7.9.2 Bayer AG Business Overview
7.9.3 Bayer AG Postmenopausal Vaginal Atrophy Therapeutics Major Product Offerings
7.9.4 Bayer AG Postmenopausal Vaginal Atrophy Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Bayer AG Key News & Latest Developments
7.10 TherapeuticsMD
7.10.1 TherapeuticsMD Company Summary
7.10.2 TherapeuticsMD Business Overview
7.10.3 TherapeuticsMD Postmenopausal Vaginal Atrophy Therapeutics Major Product Offerings
7.10.4 TherapeuticsMD Postmenopausal Vaginal Atrophy Therapeutics Revenue in Global Market (2018-2023)
7.10.5 TherapeuticsMD Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Postmenopausal Vaginal Atrophy Therapeutics Market Opportunities & Trends in Global Market
Table 2. Postmenopausal Vaginal Atrophy Therapeutics Market Drivers in Global Market
Table 3. Postmenopausal Vaginal Atrophy Therapeutics Market Restraints in Global Market
Table 4. Key Players of Postmenopausal Vaginal Atrophy Therapeutics in Global Market
Table 5. Top Postmenopausal Vaginal Atrophy Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Postmenopausal Vaginal Atrophy Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Postmenopausal Vaginal Atrophy Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Postmenopausal Vaginal Atrophy Therapeutics Product Type
Table 9. List of Global Tier 1 Postmenopausal Vaginal Atrophy Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Postmenopausal Vaginal Atrophy Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Postmenopausal Vaginal Atrophy Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Postmenopausal Vaginal Atrophy Therapeutics Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Postmenopausal Vaginal Atrophy Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Postmenopausal Vaginal Atrophy Therapeutics Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2024-2032
Table 30. Endoceutics Company Summary
Table 31. Endoceutics Postmenopausal Vaginal Atrophy Therapeutics Product Offerings
Table 32. Endoceutics Postmenopausal Vaginal Atrophy Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Endoceutics Key News & Latest Developments
Table 34. Accord Healthcare Company Summary
Table 35. Accord Healthcare Postmenopausal Vaginal Atrophy Therapeutics Product Offerings
Table 36. Accord Healthcare Postmenopausal Vaginal Atrophy Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Accord Healthcare Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Postmenopausal Vaginal Atrophy Therapeutics Product Offerings
Table 40. Pfizer Postmenopausal Vaginal Atrophy Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Key News & Latest Developments
Table 42. Novo Nordisk Company Summary
Table 43. Novo Nordisk Postmenopausal Vaginal Atrophy Therapeutics Product Offerings
Table 44. Novo Nordisk Postmenopausal Vaginal Atrophy Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Novo Nordisk Key News & Latest Developments
Table 46. Teva Pharmaceuticals Company Summary
Table 47. Teva Pharmaceuticals Postmenopausal Vaginal Atrophy Therapeutics Product Offerings
Table 48. Teva Pharmaceuticals Postmenopausal Vaginal Atrophy Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Teva Pharmaceuticals Key News & Latest Developments
Table 50. Shionogi Company Summary
Table 51. Shionogi Postmenopausal Vaginal Atrophy Therapeutics Product Offerings
Table 52. Shionogi Postmenopausal Vaginal Atrophy Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Shionogi Key News & Latest Developments
Table 54. Bionovo Company Summary
Table 55. Bionovo Postmenopausal Vaginal Atrophy Therapeutics Product Offerings
Table 56. Bionovo Postmenopausal Vaginal Atrophy Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Bionovo Key News & Latest Developments
Table 58. QuatRx Pharmaceutical Company Company Summary
Table 59. QuatRx Pharmaceutical Company Postmenopausal Vaginal Atrophy Therapeutics Product Offerings
Table 60. QuatRx Pharmaceutical Company Postmenopausal Vaginal Atrophy Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. QuatRx Pharmaceutical Company Key News & Latest Developments
Table 62. Bayer AG Company Summary
Table 63. Bayer AG Postmenopausal Vaginal Atrophy Therapeutics Product Offerings
Table 64. Bayer AG Postmenopausal Vaginal Atrophy Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Bayer AG Key News & Latest Developments
Table 66. TherapeuticsMD Company Summary
Table 67. TherapeuticsMD Postmenopausal Vaginal Atrophy Therapeutics Product Offerings
Table 68. TherapeuticsMD Postmenopausal Vaginal Atrophy Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. TherapeuticsMD Key News & Latest Developments
List of Figures
Figure 1. Postmenopausal Vaginal Atrophy Therapeutics Segment by Type in 2022
Figure 2. Postmenopausal Vaginal Atrophy Therapeutics Segment by Application in 2022
Figure 3. Global Postmenopausal Vaginal Atrophy Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Postmenopausal Vaginal Atrophy Therapeutics Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Postmenopausal Vaginal Atrophy Therapeutics Revenue in 2022
Figure 8. By Type - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share, 2018-2032
Figure 9. By Application - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share, 2018-2032
Figure 10. By Type - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share, 2018-2032
Figure 12. By Application - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share, 2018-2032
Figure 14. By Region - Global Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share, 2018-2032
Figure 15. By Country - North America Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share, 2018-2032
Figure 16. US Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share, 2018-2032
Figure 20. Germany Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 21. France Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share, 2018-2032
Figure 28. China Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 32. India Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share, 2018-2032
Figure 34. Brazil Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share, 2018-2032
Figure 37. Turkey Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Postmenopausal Vaginal Atrophy Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 41. Endoceutics Postmenopausal Vaginal Atrophy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Accord Healthcare Postmenopausal Vaginal Atrophy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer Postmenopausal Vaginal Atrophy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novo Nordisk Postmenopausal Vaginal Atrophy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Teva Pharmaceuticals Postmenopausal Vaginal Atrophy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Shionogi Postmenopausal Vaginal Atrophy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bionovo Postmenopausal Vaginal Atrophy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. QuatRx Pharmaceutical Company Postmenopausal Vaginal Atrophy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bayer AG Postmenopausal Vaginal Atrophy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. TherapeuticsMD Postmenopausal Vaginal Atrophy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
